Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Research
Open Access

The mobility gap: estimating mobility thresholds required to control SARS-CoV-2 in Canada

Kevin A. Brown, Jean-Paul R. Soucy, Sarah A. Buchan, Shelby L. Sturrock, Isha Berry, Nathan M. Stall, Peter Jüni, Amir Ghasemi, Nicholas Gibb, Derek R. MacFadden and Nick Daneman
CMAJ April 26, 2021 193 (17) E592-E600; DOI: https://doi.org/10.1503/cmaj.210132
Kevin A. Brown
Public Health Ontario (Brown, Buchan, Daneman); Dalla Lana School of Public Health (Brown, Soucy, Buchan, Sturrock, Berry), and The Institute for Health Policy, Management, and Evaluation (Stall, Jüni, Daneman), University of Toronto; Applied Health Research Centre, St. Michael’s Hospital (Jüni); Sinai Health System and the University Health Network (Stall); Women’s College Hospital (Stall); Department of Medicine (Stall, Daneman), University of Toronto, Toronto, Ont.; Communications Research Centre Canada (Ghasemi); Public Health Agency of Canada (Gibb); Ottawa Hospital Research Institute (MacFadden), Ottawa, Ont.; Division of Infectious Diseases (Daneman), Sunnybrook Research Institute, Toronto, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean-Paul R. Soucy
Public Health Ontario (Brown, Buchan, Daneman); Dalla Lana School of Public Health (Brown, Soucy, Buchan, Sturrock, Berry), and The Institute for Health Policy, Management, and Evaluation (Stall, Jüni, Daneman), University of Toronto; Applied Health Research Centre, St. Michael’s Hospital (Jüni); Sinai Health System and the University Health Network (Stall); Women’s College Hospital (Stall); Department of Medicine (Stall, Daneman), University of Toronto, Toronto, Ont.; Communications Research Centre Canada (Ghasemi); Public Health Agency of Canada (Gibb); Ottawa Hospital Research Institute (MacFadden), Ottawa, Ont.; Division of Infectious Diseases (Daneman), Sunnybrook Research Institute, Toronto, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarah A. Buchan
Public Health Ontario (Brown, Buchan, Daneman); Dalla Lana School of Public Health (Brown, Soucy, Buchan, Sturrock, Berry), and The Institute for Health Policy, Management, and Evaluation (Stall, Jüni, Daneman), University of Toronto; Applied Health Research Centre, St. Michael’s Hospital (Jüni); Sinai Health System and the University Health Network (Stall); Women’s College Hospital (Stall); Department of Medicine (Stall, Daneman), University of Toronto, Toronto, Ont.; Communications Research Centre Canada (Ghasemi); Public Health Agency of Canada (Gibb); Ottawa Hospital Research Institute (MacFadden), Ottawa, Ont.; Division of Infectious Diseases (Daneman), Sunnybrook Research Institute, Toronto, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shelby L. Sturrock
Public Health Ontario (Brown, Buchan, Daneman); Dalla Lana School of Public Health (Brown, Soucy, Buchan, Sturrock, Berry), and The Institute for Health Policy, Management, and Evaluation (Stall, Jüni, Daneman), University of Toronto; Applied Health Research Centre, St. Michael’s Hospital (Jüni); Sinai Health System and the University Health Network (Stall); Women’s College Hospital (Stall); Department of Medicine (Stall, Daneman), University of Toronto, Toronto, Ont.; Communications Research Centre Canada (Ghasemi); Public Health Agency of Canada (Gibb); Ottawa Hospital Research Institute (MacFadden), Ottawa, Ont.; Division of Infectious Diseases (Daneman), Sunnybrook Research Institute, Toronto, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Isha Berry
Public Health Ontario (Brown, Buchan, Daneman); Dalla Lana School of Public Health (Brown, Soucy, Buchan, Sturrock, Berry), and The Institute for Health Policy, Management, and Evaluation (Stall, Jüni, Daneman), University of Toronto; Applied Health Research Centre, St. Michael’s Hospital (Jüni); Sinai Health System and the University Health Network (Stall); Women’s College Hospital (Stall); Department of Medicine (Stall, Daneman), University of Toronto, Toronto, Ont.; Communications Research Centre Canada (Ghasemi); Public Health Agency of Canada (Gibb); Ottawa Hospital Research Institute (MacFadden), Ottawa, Ont.; Division of Infectious Diseases (Daneman), Sunnybrook Research Institute, Toronto, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nathan M. Stall
Public Health Ontario (Brown, Buchan, Daneman); Dalla Lana School of Public Health (Brown, Soucy, Buchan, Sturrock, Berry), and The Institute for Health Policy, Management, and Evaluation (Stall, Jüni, Daneman), University of Toronto; Applied Health Research Centre, St. Michael’s Hospital (Jüni); Sinai Health System and the University Health Network (Stall); Women’s College Hospital (Stall); Department of Medicine (Stall, Daneman), University of Toronto, Toronto, Ont.; Communications Research Centre Canada (Ghasemi); Public Health Agency of Canada (Gibb); Ottawa Hospital Research Institute (MacFadden), Ottawa, Ont.; Division of Infectious Diseases (Daneman), Sunnybrook Research Institute, Toronto, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Jüni
Public Health Ontario (Brown, Buchan, Daneman); Dalla Lana School of Public Health (Brown, Soucy, Buchan, Sturrock, Berry), and The Institute for Health Policy, Management, and Evaluation (Stall, Jüni, Daneman), University of Toronto; Applied Health Research Centre, St. Michael’s Hospital (Jüni); Sinai Health System and the University Health Network (Stall); Women’s College Hospital (Stall); Department of Medicine (Stall, Daneman), University of Toronto, Toronto, Ont.; Communications Research Centre Canada (Ghasemi); Public Health Agency of Canada (Gibb); Ottawa Hospital Research Institute (MacFadden), Ottawa, Ont.; Division of Infectious Diseases (Daneman), Sunnybrook Research Institute, Toronto, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amir Ghasemi
Public Health Ontario (Brown, Buchan, Daneman); Dalla Lana School of Public Health (Brown, Soucy, Buchan, Sturrock, Berry), and The Institute for Health Policy, Management, and Evaluation (Stall, Jüni, Daneman), University of Toronto; Applied Health Research Centre, St. Michael’s Hospital (Jüni); Sinai Health System and the University Health Network (Stall); Women’s College Hospital (Stall); Department of Medicine (Stall, Daneman), University of Toronto, Toronto, Ont.; Communications Research Centre Canada (Ghasemi); Public Health Agency of Canada (Gibb); Ottawa Hospital Research Institute (MacFadden), Ottawa, Ont.; Division of Infectious Diseases (Daneman), Sunnybrook Research Institute, Toronto, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicholas Gibb
Public Health Ontario (Brown, Buchan, Daneman); Dalla Lana School of Public Health (Brown, Soucy, Buchan, Sturrock, Berry), and The Institute for Health Policy, Management, and Evaluation (Stall, Jüni, Daneman), University of Toronto; Applied Health Research Centre, St. Michael’s Hospital (Jüni); Sinai Health System and the University Health Network (Stall); Women’s College Hospital (Stall); Department of Medicine (Stall, Daneman), University of Toronto, Toronto, Ont.; Communications Research Centre Canada (Ghasemi); Public Health Agency of Canada (Gibb); Ottawa Hospital Research Institute (MacFadden), Ottawa, Ont.; Division of Infectious Diseases (Daneman), Sunnybrook Research Institute, Toronto, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Derek R. MacFadden
Public Health Ontario (Brown, Buchan, Daneman); Dalla Lana School of Public Health (Brown, Soucy, Buchan, Sturrock, Berry), and The Institute for Health Policy, Management, and Evaluation (Stall, Jüni, Daneman), University of Toronto; Applied Health Research Centre, St. Michael’s Hospital (Jüni); Sinai Health System and the University Health Network (Stall); Women’s College Hospital (Stall); Department of Medicine (Stall, Daneman), University of Toronto, Toronto, Ont.; Communications Research Centre Canada (Ghasemi); Public Health Agency of Canada (Gibb); Ottawa Hospital Research Institute (MacFadden), Ottawa, Ont.; Division of Infectious Diseases (Daneman), Sunnybrook Research Institute, Toronto, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nick Daneman
Public Health Ontario (Brown, Buchan, Daneman); Dalla Lana School of Public Health (Brown, Soucy, Buchan, Sturrock, Berry), and The Institute for Health Policy, Management, and Evaluation (Stall, Jüni, Daneman), University of Toronto; Applied Health Research Centre, St. Michael’s Hospital (Jüni); Sinai Health System and the University Health Network (Stall); Women’s College Hospital (Stall); Department of Medicine (Stall, Daneman), University of Toronto, Toronto, Ont.; Communications Research Centre Canada (Ghasemi); Public Health Agency of Canada (Gibb); Ottawa Hospital Research Institute (MacFadden), Ottawa, Ont.; Division of Infectious Diseases (Daneman), Sunnybrook Research Institute, Toronto, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF
Loading

Abstract

BACKGROUND: Nonpharmaceutical interventions remain the primary means of controlling severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) until vaccination coverage is sufficient to achieve herd immunity. We used anonymized smartphone mobility measures to quantify the mobility level needed to control SARS-CoV-2 (i.e., mobility threshold), and the difference relative to the observed mobility level (i.e., mobility gap).

METHODS: We conducted a time-series study of the weekly incidence of SARS-CoV-2 in Canada from Mar. 15, 2020, to Mar. 6, 2021. The outcome was weekly growth rate, defined as the ratio of cases in a given week versus the previous week. We evaluated the effects of average time spent outside the home in the previous 3 weeks using a log-normal regression model, accounting for province, week and mean temperature. We calculated the SARS-CoV-2 mobility threshold and gap.

RESULTS: Across the 51-week study period, a total of 888 751 people were infected with SARS-CoV-2. Each 10% increase in the mobility gap was associated with a 25% increase in the SARS-CoV-2 weekly case growth rate (ratio 1.25, 95% confidence interval 1.20–1.29). Compared to the prepandemic baseline mobility of 100%, the mobility threshold was highest in the summer (69%; interquartile range [IQR] 67%–70%), and dropped to 54% in winter 2021 (IQR 52%–55%); a mobility gap was present in Canada from July 2020 until the last week of December 2020.

INTERPRETATION: Mobility strongly and consistently predicts weekly case growth, and low levels of mobility are needed to control SARS-CoV-2 through spring 2021. Mobility measures from anonymized smartphone data can be used to guide provincial and regional loosening and tightening of physical distancing measures.

The global toll of coronavirus disease 2019 (COVID-19) continues to grow, despite the promise of recently approved vaccines. A surge is occurring in many countries in the Northern Hemisphere, including Canada, that may take a considerable toll before vaccination is sufficiently widespread to achieve herd immunity. Nonpharmaceutical public health interventions, including physical distancing, remain the primary population-based means of controlling COVID-19.1 Since early in the second wave, which started in September 2020, polling has suggested that most people in Canada have supported and adhered to government-directed restrictions,2 and many favour strengthened measures to control community transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative viral agent of COVID-19.3

SARS-CoV-2 is spread primarily through close contact with people who are infected.4 As with any infectious disease, contact rates are a primary driver of SARS-CoV-2 transmission.5 Mobility measures capturing human activity through anonymized tracking of smartphones are believed to be reasonable proxies of contact rates outside of one’s own home; these measures can provide more timely and reliable sources of information on contact rates compared with time-use surveys or contact tracing.6–8

Aggregated smartphone mobility data are provided by a number of software developers and have been used to quantify the impact of policy on mobility in Canada,9 the effectiveness of lockdowns aiming to reduce the spread of SARS-CoV-210–12 and loopholes from excessively localized measures.13 Mobility metrics are helpful for gauging the effect of restrictions on behaviour, but do not, on their own, show decision-makers whether restrictions in place at the time are sufficient to curtail the spread of SARS-CoV-2. In this study, we evaluated the association between smartphone mobility measures and the spread of SARS-CoV-2 in Canada, both nationally and provincially, between March 2020 and March 2021. We also sought to quantify the mobility level needed to control COVID-19 (i.e., the mobility threshold), and the difference between observed mobility levels and the threshold (i.e., the mobility gap). We hypothesized that lower mobility levels may be needed in provinces with larger urban populations in the winter compared with more rural provinces in the summer.14

Methods

Study design

We conducted a time-series study of the impact of mobility on weekly SARS-CoV-2 incidence in Canada between Mar. 15, 2020, and Mar. 6, 2021. The study was conducted at both the national and provincial levels. For analyses at the provincial level, only weeks with an incidence greater than 20 cases in the previous week were included, because incidence rates during weeks with small case counts are likely to be considerably affected by importation and sporadic outbreaks. Based on visual inspection of model fit, we included only provinces or territories for which at least 50% of weeks were eligible for inclusion in the province-level analyses, to ensure that province-specific estimates were accurate. When several disjoint segments of eligible weeks from the same province were eligible, we included the longest segment.

Outcome

We measured the weekly case counts and test positivity for SARS-CoV-2 in each province using data from the COVID-19 Canada Open Data Working Group15 in the 51-week period from Mar. 15, 2020, to Mar. 6, 2021. Outcomes were aggregated by week in order to control for daily patterns evident in Canadian case reporting data.16 The Open Data Working Group obtains and compiles daily case counts reported across the country by provincial public health agencies, accredited news media and official social media accounts. Weeks were defined as starting on Sunday and ending on Saturday.

Because we hypothesized that mobility would impact SARS-CoV-2 dynamics in terms of changes in rates, rather than absolute levels of infection, our outcome was the weekly growth rate, measured as the ratio of SARS-CoV-2 cases in a given week divided by the number of SARS-CoV-2 cases in the previous week. A weekly growth rate equal to 1 meant that incidence was stable relative to the previous week, and a weekly growth rate greater than 1 meant that cases increased. Because surveillance data are subject to time-varying underdetection, we developed a corrected growth rate, equal to the weekly growth rate of cases multiplied by the weekly growth rate of test positivity.

Mobility measures

Province-level smartphone mobility data were drawn from opensource Google Community Mobility Reports,17 which are updated daily. These data are collected from select users of Google Maps who have enabled the location history setting, which is turned off by default. The primary exposure of interest was the average time spent outside of home in the previous 3-week period, which has been validated and is a strong indicator of the introduction and lifting of nonpharmaceutical public health interventions.18 This lag period was chosen based on a 10-day buffer around the known peak correlation between mobility and case growth rate at 11 days.12

We defined the baseline level of the mobility measure as its median value during the 5-week period from Jan. 3 to Feb. 6, 2020, namely the 1-month period before the first confirmed case of community transmission in Canada (Mar. 5 in British Columbia) and before the first school closures in Canada (Mar. 15 in Ontario). We rescaled the Google residential mobility values (formula: 100 × [1 − X/30]; estimating that, in winter, Canadians spend 30% of time outside the home) so that levels in the baseline period represented 100%, with a range from 0% (no out-of-home mobility) to values greater than 100%.8,9 For the purposes of plotting out-of-home mobility, we smoothed the index values using a penalized spline with a knot for each 2-week period,19 and also superimposed a 7-day rolling average.

Covariates

In addition to mobility, we controlled for week and average temperature (degrees centigrade) in a 3-week lag period of the most populous city of each province, based on Environment Canada data.20 For descriptive purposes, we grouped weeks in the same quarter together: March 2020, April–June 2020, July–September 2020, October–December 2020 and January–March 2021.

Analysis

We described the weekly case growth rates, positivity and nonresidential mobility levels across provinces and quarters with the median and interquartile range (IQR). We modelled the logarithm of weekly SARS-CoV-2 growth using a Gaussian regression model. Covariate coefficients from this model were exponentiated and represented growth rate ratios (GRRs). Factors with GRR values greater than 1 were associated with accelerating growth; factors with GRR values less than 1 were associated with decelerating growth. For the primary (uncorrected for test positivity) and secondary (corrected for test positivity) outcomes, we developed 2 regression models: an unadjusted model that included out-of-home mobility in the previous 3-week period and penalized spline for the week (with a knot for every 2-month period), and an adjusted model that also accounted for mean temperature in the previous 3 weeks as a linear covariate. All models were fit using the mgcv package in R (model details in Appendix 1, available at www.cmaj.ca/lookup/doi/10.1503/cmaj.210132/tab-related-content).19,21

Using the adjusted model of the association between SARS-CoV-2 growth rate and mobility, we estimated the mobility threshold at which SARS-CoV-2 growth would cease to occur. The calculation of the mobility threshold is detailed in Appendix 1. We defined the mobility gap as the difference between the observed mobility and the mobility threshold. The mobility gap can be interpreted as the estimated incremental reduction in mobility that would have been needed to achieve control of SARS-CoV-2 growth rate in a given province in a given week.

To enable model comparison, we measured several model diagnostics, including the Pearson residual autocorrelation at 1 week of lag, the model R2 (1 − deviancemodel/deviancenull), the estimated model degrees of freedom (taking penalties into consideration) and the model Akaikes’ Information Criterion (AIC; equal to the sum of the model deviance plus the model degrees of freedom), a measure of model fit where smaller values indicate more parsimonious and better-fitting models.

Ethics approval

All data used in this study were in the public domain; therefore the study was exempt from review by the University of Toronto Research Ethics Board.

Results

Across the 51-week period (Mar. 15, 2020, to Mar. 6, 2021), there were 888 751 cases of SARS-CoV-2 in Canada (Table 1). All cases were included in the national analysis, and 881 009 (99.1%) were included in the province-level analyses, which included 279 eligible province-weeks. Ontario (n = 311 810) and Quebec (n = 289 583) had the highest number of eligible SARS-CoV-2 cases.

View this table:
  • View inline
  • View popup
Table 1:

Weekly SARS-CoV-2 test positivity, case growth rates and mobility in Canada, Mar. 15, 2020, to Mar. 6, 2021

Across Canada, out-of-home mobility dropped rapidly in March 2020 to reach a low of 23% in the week of April 5 (Figure 1). Mobility increased through the summer of 2020 and reached levels approaching baseline in the week of August 23 (78%), and then decreased slowly through the fall months and rapidly in December 2020. Manitoba was unique, with mobility levels dropping comparatively more than other provinces during the fall of 2020.

Figure 1:
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1:

Out-of-home mobility (A) across Canada and (B) in 6 Canadian provinces, Feb. 5, 2020, to Mar. 6, 2021. Note: The out-of-home mobility index is a measure of the average amount of time spent outside the home, based on smartphone mobility data (the index is scaled so that levels in the baseline period from Jan. 3 to Feb. 6, 2020, represent 100%). The index values are smoothed using a penalized spline with a knot for each 2-week period (bold line) and are superposed with a 7-day rolling average (pale line).

Mobility and SARS-CoV-2 growth rate

In the national model, adjusting for both date and temperature effects, each 10% increase in mobility was associated with a 25% increase in the weekly growth rate (adjusted GRR 1.25 per 10% increase in mobility, 95% confidence interval [CI] 1.20–1.29) (Table 2 and Figure 2). Increases in mean weekly temperature were significantly associated with decreased SARS-CoV-2 growth rates (GRR 0.83 per 5°C increase, 95% CI 0.75–0.93). Model diagnostics indicated low levels of residual autocorrelation (Pearson correlation, adjusted model = 0.15), and that model fit was strong (R2, adjusted model = 81.6%). The positivity-corrected outcome was missing for 2 weeks, leaving 49 weeks in the analysis. Results were similar with this outcome (adjusted GRR 1.35 per 10% increase in mobility, 95% CI 1.17–1.55), though overall model fit was worse (R2 = 56.2%)

View this table:
  • View inline
  • View popup
Table 2:

Factors influencing SARS-CoV-2 weekly growth rates and positivity-corrected growth-rates, across Canada, Mar. 15, 2020, to Mar. 6, 2021

Figure 2:
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2:

Adjusted-association between out-of-home mobility and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) growth rate across 6 Canadian provinces, Mar. 15, 2020, to Mar. 6, 2021. Weekly SARS-CoV-2 growth rate (cases in given week/cases in previous week) is strongly associated with the out-of-home mobility in the prior 3-week period. In the adjusted Canada-level analysis, each 10% increase in out-of-home mobility was associated with a 25% increase in the growth rate (growth rate ratio [GRR] 1.25, 95% confidence interval [CI] 1.20–1.29). In the adjusted province-level analysis, each 10% increase in mobility was associated with a 20% increase in the growth rate ratio (GRR 1.20, 95% CI 1.16–1.24). These associations are represented by the dotted lines.

In provincial-level analyses, adjusting for both date and temperature effects, each 10% increase in mobility was associated with a 20% increase in the weekly growth rate (adjusted GRR 1.20, 95% CI 1.16–1.24), and increasing temperature was associated with lower growth rates (GRR 0.88 per 5°C increase in temperature, 95% CI 0.86–0.91). Model fit for the provincial level models was weaker (R2, adjusted model = 38.2%). The positivity-corrected outcome was missing for 10 weeks, leaving 269 province-weeks in the analysis. A strong association between mobility and the positivity-corrected growth rate was also apparent (adjusted GRR 1.29 per 10% increase in mobility, 95% CI 1.21–1.38).

Mobility threshold and mobility gap

We used the adjusted national and provincial models to measure the mobility threshold (Figure 3). The national mobility threshold varied markedly through the pandemic period and was highest in the summer (median 71%, IQR 69%–72%), and dropped throughout the fall to 54% (IQR 52%–55%) in the winter. Variations across provinces in the estimated mobility threshold were also apparent; Ontario (50%, IQR 46%–59%) and Quebec (54%, IQR 52%–63%) had the lowest thresholds.

Figure 3:
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3:

Variation in 3-week rolling average of mobility (coloured points) and the estimated mobility threshold (black line) and 80% confidence intervals (shaded region) for (A) Canada and (B) 6 Canadian provinces. Size of circles is proportional to the number of cases in a given week. Note: The mobility threshold is the estimated level of mobility needed to control severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) case growth. This threshold is highest in summer and is lowest in the most populated provinces, particularly in Ontario (median 50%) and Quebec (median 54%). When mobility decreased below the mobility threshold in spring 2020 and winter 2021, weekly SARS-CoV-2 case counts decreased. In late November 2020, Manitoba was the only province that successfully crossed the mobility threshold, which led to reductions in SARS-CoV-2 case growth. Other provinces attained this only in late December 2020 or early January 2021.

The mobility gap in Canadian provinces passed through distinct phases over the course of the pandemic (Figure 3). At the onset of the pandemic in March 2020, out-of-home mobility was in excess of the mobility threshold. Strict lockdown measures led to rapid declines in mobility below the threshold and control of the SARS-CoV-2 growth rate (April–May). Easing of lockdown measures in the late spring coincided with increasing mobility thresholds, but mobility soon increased to exceed the threshold needed to control SARS-CoV-2 in the summer of 2020. Mobility thresholds decreased throughout the fall and mobility remained above the threshold, coinciding with surging case counts. In November 2020, Manitoba markedly reduced mobility to levels below the mobility threshold, but mobility in Canada dropped below the threshold only in the last week of December.

Interpretation

Our evaluation of predictors of weekly SARS-CoV-2 growth rates across Canada shows that reductions in mobility strongly predict future control of SARS-CoV-2 growth rates in the subsequent 3-week period, and suggests that more substantial reductions in mobility were required to control transmission of SARS-CoV-2 through the fall of 2020. We developed measures of the estimated mobility level required to achieve SARS-CoV-2 control in Canada (the mobility threshold), and the estimated mobility reduction required to control SARS-CoV-2 growth (the mobility gap).

This study builds on work showing strong associations between physical distancing measures and the incidence of SARS-CoV-2.11,22,23 Studies using smartphone mobility measures show that changes in mobility specifically predict SARS-CoV-2 incidence in the subsequent 1–3 weeks.12 More detailed mobility data suggest that dine-in restaurants, take-out services (likely representing risk for workers more than customers), gyms and cafés are particularly important drivers of SARS-CoV-2 incidence in the United States.24 A mobility threshold necessary to control SARS-CoV-2 spread can be measured.25 We have shown that the mobility reductions required are seasonally dependent — relatively small reductions were required to control SARS-CoV-2 in the summer of 2020, but larger mobility reductions have been needed since the fall.

As with several respiratory pathogens,26,27 we observed substantial seasonal variation in the risk of SARS-CoV-2 infection. Substantial controversy remains as to the underlying drivers of the increased incidence in the winter. Hypotheses include human behavioural factors, particularly the increased time spent in poorly ventilated indoor environments, increased virus survival in winter climatic conditions (in particular, decreased absolute humidity)28 and factors related to the immune system.26

Our work suggests that if governments and public health agencies wish to suppress community transmission of SARS-CoV-2 through the spring of 2021, before vaccination is widespread, stringent nonpharmaceutical interventions may be necessary. Manitoba, which lowered mobility sufficiently to achieve control of SARS-CoV-2 in the fall, did so by moving the entire province into the most stringent lockdown level on Nov. 12, 2020. Measures included restricting private gatherings to 5 persons, closing nonessential businesses and in-restaurant dining29 and increasing enforcement (almost $1 million in fines given out by early January 2021).30,31

Limitations

We did not examine granular patterns of mobility within provinces, limiting potential insights into the effectiveness of the regional approaches pursued in some provinces. We used comparative measures of mobility relative to levels in January 2020 rather than absolute counts, which added to the complexity of interprovincial comparisons. Further, the Google Community Mobility Reports may not be representative of the Ontario population as a whole, and the data compiled by the Canadian Open Data Working Group have not been formally validated. The SARS-CoV-2 growth rates that we observed may be temporally dependent, which could lead to underestimation of coefficient standard errors; model diagnostics suggested that autocorrelation was weak. Weather was crudely measured based on the most populous city of the province. We considered only a limited number of potential confounding variables and did not control for SARS-CoV-2 vaccination levels. Vaccines were first administered in Canada on Dec. 14, 2020, and remain well below herd immunity levels as of March 2021. As vaccination rates increase, this could be embedded into models of the predicted mobility threshold. Meanwhile, the rapidly spreading variants arising from the United Kingdom and South Africa32 may need a lower mobility threshold to control the spread of SARS-CoV-2.

Conclusion

This study shows that mobility strongly predicts the growth rate of SARS-CoV-2 up to 3 weeks in the future, and that stringent measures will continue to be necessary through spring 2021 in Canada. The mobility threshold and mobility gap can be used by public health officials and governments to estimate the level of restrictions needed to control the spread of SARS-CoV-2 and guide, in real-time, the implementation and intensity of non-pharmaceutical public health interventions to control the COVID-19 pandemic.

Footnotes

  • Competing interests: Kevin Brown, Nathan Stall and Peter Jüni are affiliated with the Ontario COVID-19 Science Advisory Table. Peter Jüni serves as an upaid member of the steering group of trials funded by Appili Therapeutics, AstraZeneca, Biotronik, Biosensors, Eli Lilly, St. Jude Medical and The Medicines Company, and has participated in advisory boards or consulted with Amgen, Ava and Fresenius, outside the submitted work. No other competing interests were declared.

  • This article has been peer reviewed.

  • Contributors: Kevin Brown conceived and designed the work. Kevin Brown, Jean-Paul Soucy and Isha Berry acquired the data, which Kevin Brown analyzed and interpreted. Kevin Brown drafted the manuscript, which all authors revised critically for important intellectual content, gave final approval of the version to be published and agreed to be accountable for all aspects of the work.

  • Data sharing: All data used in this study are in the public domain. Mobility data are available at https://www.google.com/covid19/mobility/. Incidence data are available at https://opencovid.ca/. Data are also available upon request.

  • Disclaimer: Nathan Stall is a associate editor for CMAJ and was not involved in the editorial decision-making process for this article.

  • Accepted March 22, 2021.

This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is noncommercial (i.e., research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/licenses/by-nc-nd/4.0/

References

  1. ↵
    1. Ferguson N,
    2. Laydon D,
    3. Nedjati Gilani G,
    4. et al
    . Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand. London (UK): Imperial College London; 2020. Available: http://spiral.imperial.ac.uk/handle/10044/1/77482 (accessed 2020 May 3).
  2. ↵
    Leger’s Weekly Survey — October 6, 2020. Leger 2020. Available: https://leger360.com/surveys/legers-weekly-survey-october-6-2020/ (accessed 2020 Dec. 16).
  3. ↵
    Seven in ten Canadians (72%) support four-week closure of non-essential businesses as Canada’s biggest city goes back into lockdown; support in Toronto at 76%. Toronto: Ipsos; 2020. Available: www.ipsos.com/en-ca/news-polls/seven-in-ten-canadians-support-four-week-closure-of-non-essential-businesses (accessed 2020 Dec. 16).
  4. ↵
    1. Klompas M,
    2. Baker MA,
    3. Rhee C
    . Airborne Transmission of SARS-CoV-2: theoretical considerations and available evidence. JAMA 2020;324:441–2.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Kucharski A
    . The rules of contagion: why things spread — and why they stop. New York: Basic Books; 2020.
  6. ↵
    1. Leech JA,
    2. Nelson WC,
    3. Burnett RT,
    4. et al
    . It’s about time: a comparison of Canadian and American time–activity patterns. J Expo Anal Environ Epidemiol 2002;12:427–32.
    OpenUrlCrossRefPubMed
    1. Matz CJ,
    2. Stieb DM,
    3. Davis K,
    4. et al
    . Effects of age, season, gender and urban-rural status on time-activity: Canadian Human Activity Pattern Survey 2 (CHAPS 2). Int J Environ Res Public Health 2014;11:2108–24.
    OpenUrl
  7. ↵
    1. Caceres N,
    2. Romero LM,
    3. Benitez FG
    . Exploring strengths and weaknesses of mobility inference from mobile phone data vs. travel surveys. Transportmetrica A: Transp Sci 2020;16:574–601.
    OpenUrl
  8. ↵
    1. Armstrong DA II.,
    2. Lebo MJ,
    3. Do Lucas J
    . COVID-19 policies affect mobility behaviour? Evidence from 75 Canadian and American cities. Can Public Policy 2020;46(Suppl 2):S127–44.
    OpenUrl
  9. ↵
    1. Kishore N,
    2. Kiang MV,
    3. Engø-Monsen K,
    4. et al
    . Measuring mobility to monitor travel and physical distancing interventions: a common framework for mobile phone data analysis. Lancet Digit Health 2020;2:e622–8.
    OpenUrl
  10. ↵
    1. Soucy J-PR,
    2. Sturrock SL,
    3. Berry I,
    4. et al
    . Estimating effects of physical distancing on the COVID-19 pandemic using an urban mobility index. medRxiv 2020 May 24. doi: 10.1101/2020.04.05.20054288.
    OpenUrlCrossRef
  11. ↵
    1. Badr HS,
    2. Du H,
    3. Marshall M,
    4. et al
    . Association between mobility patterns and COVID-19 transmission in the USA: a mathematical modelling study. Lancet Infect Dis 2020;20:1247–54.
    OpenUrlCrossRef
  12. ↵
    1. Yang J,
    2. Allen A,
    3. Bailey A
    . What cellphone mobility data can teach us about why lockdown might not be working, and what to expect from the holidays. The Toronto Star 2020 Dec. 13. Available: www.thestar.com/news/gta/2020/12/13/what-cellphone-mobility-data-can-teach-us-about-whos-driving-covid-infections-in-toronto-and-what-to-expect-from-the-holidays.html (accessed 2021 Mar. 5).
  13. ↵
    1. Hamidi S,
    2. Ewing R,
    3. Sabouri S
    . Longitudinal analyses of the relationship between development density and the COVID-19 morbidity and mortality rates: Early evidence from 1,165 metropolitan counties in the United States. Health Place 2020;64:102378.
    OpenUrl
  14. ↵
    1. Berry I,
    2. Soucy J-PR,
    3. Tuite A,
    4. et al
    .; COVID-19 Canada Open Data Working Group. Open access epidemiologic data and an interactive dashboard to monitor the COVID-19 outbreak in Canada. CMAJ 2020;192:E420.
    OpenUrlFREE Full Text
  15. ↵
    1. Bukhari Q,
    2. Jameel Y,
    3. Massaro JM,
    4. et al
    . Periodic oscillations in daily reported infections and deaths for coronavirus disease 2019. JAMA Netw Open 2020;3 e2017521.
    OpenUrl
  16. ↵
    COVID-19 Community Mobility Reports. Google. Available: www.google.com/covid19/mobility/ (accessed 2020 Dec. 19).
  17. ↵
    1. Li Y,
    2. Campbell H,
    3. Kulkarni D,
    4. et al
    .; Usher Network for COVID-19 Evidence Reviews (UNCOVER) group. The temporal association of introducing and lifting non-pharmaceutical interventions with the time-varying reproduction number (R) of SARS-CoV-2: a modelling study across 131 countries. Lancet Infect Dis 2021;21:193–202.
    OpenUrl
  18. ↵
    1. Wood SN
    . Generalized additive models: an introduction with R. Boca Raton (FL): Chapman & Hall/CRC; 2006:1–391.
  19. ↵
    1. LaZerte SE,
    2. Albers S
    . weathercan: download and format weather data from Environment and Climate Change Canada. J Open Source Softw 2018;3:571.
    OpenUrl
  20. ↵
    1. Pedersen EJ,
    2. Miller DL,
    3. Simpson GL,
    4. et al
    . Hierarchical generalized additive models in ecology: an introduction with mgcv. PeerJ 2019;7:e6876.
    OpenUrlCrossRefPubMed
  21. ↵
    1. Haug N,
    2. Geyrhofer L,
    3. Londei A,
    4. et al
    . Ranking the effectiveness of worldwide COVID-19 government interventions. Nat Hum Behav 2020;4:1303–12.
    OpenUrlPubMed
  22. ↵
    1. Brauner JM,
    2. Mindermann S,
    3. Sharma M,
    4. et al
    . Inferring the effectiveness of government interventions against COVID-19. Science 2021;371:eabd9338.
    OpenUrlAbstract/FREE Full Text
  23. ↵
    1. Chang S,
    2. Pierson E,
    3. Koh PW,
    4. et al
    . Mobility network models of COVID-19 explain inequities and inform reopening. Nature 2021;589:82–7.
    OpenUrlPubMed
  24. ↵
    1. Nouvellet P,
    2. Bhatia S,
    3. Cori A,
    4. et al
    . Reduction in mobility and COVID-19 transmission. Nat Commun 2021;12:1090.
    OpenUrl
  25. ↵
    1. Moriyama M,
    2. Hugentobler WJ,
    3. Iwasaki A
    . Seasonality of respiratory viral infections. Annu Rev Virol 2020;7:83–101.
    OpenUrl
  26. ↵
    1. Fisman DN
    . Seasonality of infectious diseases. Annu Rev Public Health 2007;28: 127–43.
    OpenUrlCrossRefPubMed
  27. ↵
    1. Shaman J,
    2. Kohn M
    . Absolute humidity modulates influenza survival, transmission, and seasonality. Proc Natl Acad Sci U S A 2009;106:3243–8.
    OpenUrlAbstract/FREE Full Text
  28. ↵
    1. Geary A
    . Manitoba’s partial lockdown moved it just below COVID-19 worst-case scenario numbers. CBC News Manitoba 2020 Dec. 4. Available: www.cbc.ca/news/canada/manitoba/manitoba-covid-19-projections-1.5828626 (accessed 2020 Dec. 22).
  29. ↵
    1. MacLean C
    . Manitoba more than doubles fines for people who violate COVID-19 orders. CBC News Manitoba 2020 Oct. 21. Available: www.cbc.ca/news/canada/manitoba/manitoba-covid-19-enforcement-fines-increasing-1.5770947 (accessed 2021 Jan. 11).
  30. ↵
    New Year’s Eve socializers dinged $14K in fines in Winnipeg. CBC News Manitoba 2021 Jan. 5. Available: www.cbc.ca/news/canada/manitoba/new-year-eve-parties-tickets-covid-19-winnipeg-1.5861628 (accessed 2021 Jan. 11).
  31. ↵
    1. Wise J
    . Covid-19: new coronavirus variant is identified in UK. BMJ 2020;371: m4857.
    OpenUrlFREE Full Text
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 193 (17)
CMAJ
Vol. 193, Issue 17
26 Apr 2021
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The mobility gap: estimating mobility thresholds required to control SARS-CoV-2 in Canada
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
The mobility gap: estimating mobility thresholds required to control SARS-CoV-2 in Canada
Kevin A. Brown, Jean-Paul R. Soucy, Sarah A. Buchan, Shelby L. Sturrock, Isha Berry, Nathan M. Stall, Peter Jüni, Amir Ghasemi, Nicholas Gibb, Derek R. MacFadden, Nick Daneman
CMAJ Apr 2021, 193 (17) E592-E600; DOI: 10.1503/cmaj.210132

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
The mobility gap: estimating mobility thresholds required to control SARS-CoV-2 in Canada
Kevin A. Brown, Jean-Paul R. Soucy, Sarah A. Buchan, Shelby L. Sturrock, Isha Berry, Nathan M. Stall, Peter Jüni, Amir Ghasemi, Nicholas Gibb, Derek R. MacFadden, Nick Daneman
CMAJ Apr 2021, 193 (17) E592-E600; DOI: 10.1503/cmaj.210132
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Methods
    • Results
    • Interpretation
    • Footnotes
    • References
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF

Related Articles

  • Écart de mobilité : estimation des seuils de mobilité requis pour maîtriser le SRAS-CoV-2 au Canada
  • PubMed
  • Google Scholar

Cited By...

  • Can tracking mobility be used as a public health tool against COVID-19 following the expiration of stay-at-home mandates?
  • Google Scholar

More in this TOC Section

  • The effect of changing screening practices and demographics on the incidence of gestational diabetes in British Columbia, 2005–2019
  • Self-reported sleep disturbances among people who have had a stroke: a cross-sectional analysis
  • Risk of interpersonal violence during and after pregnancy among people with schizophrenia: a population-based cohort study
Show more Research

Similar Articles

Collections

  • Topics
    • Canadian government
    • Epidemiology & epidemiological methods
    • Health policy
    • Infectious diseases: COVID-19
    • Public health

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire